Regulating artificial intelligence in community pharmacy: aligning primary care governance with clinical function
The Lancet Primary Care · 2026-03 · 2 (3) · 100134
DOI: 10.1016/j.lanprc.2026.100134 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Lancet Primary Care, 2026-03. Verfasst von Esteban Zavaleta-Monestel und 2 weiteren Autor:innen. Die Arbeit nennt 7 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Artificial intelligence (AI) increasingly influences prescribing, medication review, and triage decisions in primary care. Machine learning systems are implemented to detect adverse drug events, optimise dosing, and support clinical decision making in routine practice.1 As the adoption of such tools accelerates, international organisations have issued ethical and governance guidance for AI in health and new legislative frameworks are reshaping regulatory expectations for high-risk clinical systems.
Zitieren
APA
Zavaleta-Monestel, E., Mora-Jimenez, J., & Arguedas-Chacon, S. (2026). Regulating artificial intelligence in community pharmacy: aligning primary care governance with clinical function. The Lancet Primary Care, 2(3), 100134. https://doi.org/10.1016/j.lanprc.2026.100134
Vancouver
Zavaleta-Monestel E, Mora-Jimenez J, Arguedas-Chacon S. Regulating artificial intelligence in community pharmacy: aligning primary care governance with clinical function. The Lancet Primary Care. 2026;2(3):100134. doi:10.1016/j.lanprc.2026.100134
BibTeX
@article{ZavaletaMonestel2026,
author = {Zavaleta-Monestel, Esteban and Mora-Jimenez, Jeaustin and Arguedas-Chacon, Sebastian},
title = {Regulating artificial intelligence in community pharmacy: aligning primary care governance with clinical function},
journal = {The Lancet Primary Care},
year = {2026},
volume = {2},
number = {3},
pages = {100134},
doi = {10.1016/j.lanprc.2026.100134}
}
EUVIMED